VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Thealoz Duo
Preclinical
I
Instituto Internacional de Medicina y Terapia (IIMET)
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[2]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Dry Eye Syndrome (DES)
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Dry Eye Syndrome (DES)
Preclinical
Completed
Clinical
Trials by Indication
[1]
Dry Eye Syndrome (DES)
1 trial
Twice-Daily Systane Complete Versus Four-Times-Daily Thealoz Duo for Dry Eye Disease: A Randomized Controlled Non-Inferiority Trial
Completed
·
I
Instituto Internacional de Medicina y Terapia (IIMET)
·
Preclinical
·
NCT07722650
·
120 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Thealoz Duo. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform
—
Drug–disease associations for Thealoz Duo. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR
—
Instituto Internacional de Medicina y Terapia (IIMET) company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Highest Phase
Preclinical
[1]
Company
I
Instituto Internacional de Medicina y Terapia (IIMET)
Related News